Grabar Law Office In The News: Micron CEO Accused Of Insider Trading In Fla. Investor Suit
By Grabar Law |
A Micron Technology Inc. shareholder has accused the company CEO and several board members of insider trading after selling $70 million worth ...
Read More 
GRABAR LAW OFFICE IN THE NEWS: Â Biotech Co.’s Facility Failures Lost Investors Money, Suit Says
By Grabar Law |
The executives and directors of biotechnology company Humacyte Inc. have been hit with a shareholder derivative suit in North Carolina ...
Read More 
GRABAR LAW OFFICE FILES ANTITRUST CLASS ACTION ON BEHALF OF MERCHANTS THAT ACCEPT VISA DEBIT CARDS
By Grabar Law |
Grabar Law Office has filed a significant class action lawsuit against Visa Inc., alleging that Visa has systematically abused its ...
Read More 
GRABAR LAW OFFICE FILES ANTITRUST CLASS ACTION ON BEHALF OF INDEPENDENT PHARMACIES AGAINST GOODRX AND MAJOR PBMS
By Grabar Law |
Grabar Law Office has filed a class action lawsuit on behalf of independent pharmacies, challenging the anticompetitive practices of GoodRx ...
Read More 
Grabar Law Office In the News: Â Pharma Co. Verrica Faces Derivative Suit Over FDA Inspection
By Grabar Law |
Current and former officers and directors of dermatological medication maker Verrica Pharmaceuticals Inc. face a shareholder derivative action alleging the ...
Read More 
Grabar Law Office In the News: Â Biotech Execs Face Investor Suit Over Medicare Claims
By Grabar Law |
Executives and directors of biopharmaceutical company Ardelyx have been hit with a shareholder derivative suit in Massachusetts federal court alleging ...
Read More 
Grabar Law Office In The News: UnitedHealth Brass Face Investor Suit Over Merger Probe
By Grabar Law |
Executives and directors of UnitedHealth Group were hit with a shareholder derivative suit alleging they concealed that the U.S. Department ...
Read More 
GRABAR LAW OFFICE IN THE NEWS:Â EQUIFAX HIT WITH ANTITRUST CLASS ACTION OVER WORK VERIFICATION SERVICES
By Grabar Law |
Data analytics giant Equifax has been accused by a pair of home mortgage lenders of monopolizing the market for electronic ...
Read More 
GRABAR LAW OFFICE IN THE NEWS: SUGAR PRICE-FIXING SUITS COMBINED IN NY
By Grabar Law |
A New York federal judge consolidated six proposed price-fixing class actions against domestic sugar producers, siding with plaintiffs who wanted ...
Read More 
GRABAR LAW OFFICE IN THE NEWS: Â NY BANK INVESTORS SPAR OVER BID TO MERGE, PAUSE SUITS
By Grabar Law |
New York Community Bancorp Inc. shareholders traded barbs in filings this week over whether a New York federal judge should ...
Read More 
Grabar Law Office In the News:Â Â Alto Neuroscience Execs Sued Over Rosy Drug Claims
By Grabar Law |
An Alto Neuroscience investor claims CEO Amit Etkin and other directors overstated the efficacy of the psychiatric biotech company's lead ...
Read More 
Grabar Law Office In the News:Â Â Marijuana Vape Antitrust Actions Consolidated In Calif.
By Grabar Law |
Five proposed antitrust class actions brought by buyers of CCell brand cannabis vape accusing the Chinese manufacturers and U.S. distributors ...
Read More 
Grabar Law Office In the News:Â Â DOJ Asks for Stay in PVC Antitrust Case Amid Criminal Probe
By Grabar Law |
The U.S. Department of Justice is asking an Illinois federal court to pause discovery in a case accusing polyvinyl chloride ...
Read More
Grabar Law Office In the News: Â DOJ Asks for Stay in PVC Antitrust Case Amid Criminal Probe
By Grabar Law |
The U.S. Department of Justice is asking an Illinois federal court to pause discovery in a case accusing polyvinyl chloride ...
Read More 
Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims
By Grabar Law |
Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...
Read More 
Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims
By Grabar Law |
Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...
Read More 
Grabar Law Office Files Federal Lawsuit Against Major Insulin Manufacturers and PBMs on Behalf of the University of Pennsylvania
By Grabar Law |
Grabar Law Office has filed a complaint on behalf of The Trustees of the University of Pennsylvania in the United ...
Read More 
Grabar Law Office In the News: Â Geron Shareholder Sues Execs Over Drug Launch Claims
By Grabar Law |
A shareholder of Geron Corp. has filed a derivative suit against current and former members of the biopharmaceutical company's top ...
Read More 
Grabar Law Office In the News: Â AI Audio Co. Brass Accused of Acquisition Accounting Errors
By Grabar Law |
Executives and directors of California-based voice recognition technology company SoundHound Inc. were hit with a shareholder derivative suit alleging they ...
Read More 
Grabar Law Office In The News: Block’s Dorsey, Others Face Derivative Suit Over AML Woes
By Grabar Law |
Officers and directors of Square and Cash App parent company Block Inc. face a shareholder derivative complaint over alleged anti-money ...
Read More